Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
K Leuow<SUP>1</SUP><SUP>,2</SUP>, D Papaventsis (
)<SUP>2</SUP><SUP>,3</SUP>, S Kourkoundi<SUP>1</SUP>, P Ioannidis<SUP>3</SUP>, S Karabela<SUP>3</SUP>, S Tsikrika<SUP>4</SUP>, I Marinou<SUP>3</SUP>, A Papavasileiou<SUP>4</SUP>, M Stone<SUP>5</SUP><SUP>,6</SUP>, F Drobniewski<SUP>5</SUP><SUP>,6</SUP>, V Paparisos<SUP>1</SUP>, E Vogiatzakis<SUP>3</SUP>
Citation style for this article: Leuow K, Papaventsis D, Kourkoundi S, Ioannidis P, Karabela S, Tsikrika S, Marinou I, Papavasileiou A, Stone M, Drobniewski F, Paparisos V, Vogiatzakis E. Fatal case of extensively drug-resistant Mycobacterium tuberculosis Beijing genotype infection in an injecting drug user, Athens, Greece, 2012. Euro Surveill. 2013;18(12)
ii=20430. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20430
Date of submission: 19 February 2013 <HR>We present the first fatal case of extensively drug-resistant tuberculosis (XDR-TB) in an injecting drug user (IDU) in Athens, Greece, co-infected with human immunodeficiency virus and hepatitis C virus and discuss the implications for public health. Despite immediate initiation of treatment, the patient?s condition gradually deteriorated and he died 16 days after hospital admission because of multiple organ failure. The contact tracing investigation revealed no further infections among the patient?s contacts.
- ------
Eurosurveillance, Volume 18, Issue 12, 21 March 2013
Rapid communications
Fatal case of extensively drug-resistant Mycobacterium tuberculosis Beijing genotype infection in an injecting drug user, Athens, Greece, 2012
Rapid communications
Fatal case of extensively drug-resistant Mycobacterium tuberculosis Beijing genotype infection in an injecting drug user, Athens, Greece, 2012
K Leuow<SUP>1</SUP><SUP>,2</SUP>, D Papaventsis (
- HIV-Unit, ?Andreas Sygros? University Hospital for Dermatology and Venerology, Athens, Greece
- These authors contributed equally to this work
- Microbiology Department, National Reference Laboratory for Mycobacteria, Athens, Greece
- Clinic for Multidrug-Resistant Tuberculosis, ?Sotiria? Chest Diseases Hospital, Athens, Greece
- National Mycobacterium Reference Laboratory, Health Protection Agency, London, United Kingdom
- Barts and the London Queen Mary?s School of Medicine and Dentistry, London, United Kingdom
Citation style for this article: Leuow K, Papaventsis D, Kourkoundi S, Ioannidis P, Karabela S, Tsikrika S, Marinou I, Papavasileiou A, Stone M, Drobniewski F, Paparisos V, Vogiatzakis E. Fatal case of extensively drug-resistant Mycobacterium tuberculosis Beijing genotype infection in an injecting drug user, Athens, Greece, 2012. Euro Surveill. 2013;18(12)
ii=20430. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20430 Date of submission: 19 February 2013 <HR>We present the first fatal case of extensively drug-resistant tuberculosis (XDR-TB) in an injecting drug user (IDU) in Athens, Greece, co-infected with human immunodeficiency virus and hepatitis C virus and discuss the implications for public health. Despite immediate initiation of treatment, the patient?s condition gradually deteriorated and he died 16 days after hospital admission because of multiple organ failure. The contact tracing investigation revealed no further infections among the patient?s contacts.